PharmaCielo Colombia Plants Additional 45,000 Medical Marijuana Plants, Pushing Total Crop to Nearly a Quarter Million
Medical marijuana company PharmaCielo Colombia Holdings S.A.S. today announced that is has planted an additional 45,000 cannabis plants, adding to the roughly 200,000 it had previously planted under its governmentally allowed quota.
The new plants are a THC-dominant variety, which due to the properties of tetrahydrocannabinols trigger a psychoactive response when smoked or ingested, whereas the earlier crop were cannabidiol, or CBD, dominant.
PharmaCielo Colombia, a subsidiary of Canadian medical marijuana firm PharmaCielo Ltd. with operations in Rionegro, expects the flowering CBD crop it previously planted in late 2017 to begin to be ready for harvest within a matter of weeks.
The company also plans to add an additional hectare of cultivation per month, as allowable under Colombian law, which PharmaCielo Colombia CEO Federico Cock-Correa categorized as representing “rigorous regulatory structures that must be complied with.”
The company’s operations in Rionegro currently span nearly 28 hectares, including 12 hectares of open-air greenhouses used for cultivation of cannabis plants.
The firm is bullish on the long-term potential for a cannabis oil market amid expectations of rising international market demand.
“As demand for medicinal cannabis oils continues to grow on an international level, the ability to have a secure source of supply, consistently high quality and purity of the product is essential,” said Anthony Wile, CEO of PharmaCielo Ltd. of Toronto. “From speaking with global healthcare clients, we know that they need to be assured of the company’s ability to consistently provide necessary volumes as well as product quality of the highest level.”
(Photo credit: SeaweedJeezus / Pixabay)